VantAI platform Revenue and Competitors
Estimated Revenue & Valuation
- VantAI platform's estimated annual revenue is currently $11M per year.
- VantAI platform's estimated revenue per employee is $169,308
Employee Data
- VantAI platform has 65 Employees.
- VantAI platform grew their employee count by 7% last year.
VantAI platform's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Co-Founder & CTO | Reveal Email/Phone |
3 | COO and CFO | Reveal Email/Phone |
4 | Head Application Engineering | Reveal Email/Phone |
5 | SVP, Head Drug Discovery | Reveal Email/Phone |
6 | Head People | Reveal Email/Phone |
7 | Head People | Reveal Email/Phone |
8 | Associate Director R&D Strategy and Operations | Reveal Email/Phone |
9 | Associate Director R&D Operations | Reveal Email/Phone |
10 | Senior Director Controller | Reveal Email/Phone |
VantAI platform Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 3 | 0% | N/A | N/A |
#2 | N/A | 20 | 43% | N/A | N/A |
#3 | $6.7M | 33 | -6% | N/A | N/A |
#4 | $34.4M | 222 | -1% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $10M | N/A |
#6 | $2M | 13 | 0% | N/A | N/A |
#7 | $7.5M | 37 | 0% | $51.6M | N/A |
#8 | $0.3M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 21 | -16% | $3.3M | N/A |
#10 | $3.6M | 20 | 5% | N/A | N/A |
What Is VantAI platform?
VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.
keywords:N/AN/A
Total Funding
65
Number of Employees
$11M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
VantAI platform News
VantAI will pair its induced proximity platform with BI's deep early discovery experience to identify targeted protein degraders with...
They will use VantAI's geometric deep learning platform to computationally streamline the design of new molecules optimized for each E3...
NEW YORK, April 13, 2022 (GLOBE NEWSWIRE) -- VantAI, an AI-first ... and Janssen will leverage VantAI's geometric deep learning platform to...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.1M | 65 | 23% | $44.4M |
#2 | $14.3M | 65 | 0% | N/A |
#3 | $7.9M | 65 | -7% | $28.1M |
#4 | $12.9M | 65 | 5% | N/A |
#5 | $12.9M | 65 | 10% | N/A |